Bafna Pharmaceuticals Ltd has added two fully automated packaging lines to its existing capacity and they have been approved by the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU).
Commenting on the approval, Mr. Mahaveer Chand Bafna, CEO of Bafna Pharmaceuticals Ltd. says, "The approval from UK- MHRA will provide further momentum to our already expanding business in the UK, Europe and other Regulated Markets. This approval will enable Bafna Pharma to increase its output and consequentially generate higher revenue and profits.
Shares of BAFNA PHARMACEUTICALS LTD. was last trading in BSE at Rs.128.75 as compared to the previous close of Rs. 130.25. The total number of shares traded during the day was 3876 in over 136 trades.
The stock hit an intraday high of Rs. 136.75 and intraday low of 123.8. The net turnover during the day was Rs. 502062.